Physician profile
Marek S Bentkowski
NPI 1437167277
$1,706.73
in general payments reported to CMS, 2019-2025
21 companies · $55.58 in 2025
The $55.58 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,012 · 2020: $196 · 2021: $153 · 2023: $90.41 · 2024: $200 · 2025: $55.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $467.03 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $205.11 | 2019-2020 | |
| Glaxosmithkline, LLC. | $181.71 | 2019-2021 | |
| Dexcom, INC. | $170.38 | 2024-2025 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Novo Nordisk INC | $124.63 | 2019-2025 | Ozempic, Wegovy |
| Genentech USA, INC. | $70.73 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $58.14 | 2019-2020 | |
| Astellas Pharma US INC | $55.61 | 2019 | |
| Amgen INC. | $46.61 | 2019-2020 | |
| Abbvie INC. | $41.84 | 2021-2023 | Vraylar |
| Allergan, INC. | $39.66 | 2019 | |
| Lilly USA, LLC | $38.11 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $38.10 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $36.02 | 2019-2020 | |
| Mylan Specialty L.P. | $34.43 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.95 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $21.79 | 2021 | |
| Philips North America LLC | $17.03 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.37 | 2019 | |
| Merck Sharp & Dohme LLC | $11.37 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $4.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marek Bentkowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.